ArticleProceedings of the National Academy of Sciences of the United States of America2012

Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.

Isao Tawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.